SynthesisThe oncologist2012

Systematic review and network meta-analysis of overall survival comparing 3 mg/kg ipilimumab with alternative therapies in the management of pretreated patients with unresectable stage III or IV melanoma.

Pascale Dequen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.